Austrian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 119 displayed.
1 2 3 4 5 6 »

Rybelsus® (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

Read more ››

By: GlobenewsWire - 04 Apr 2020

Sanofi: Availability of the Pre-quarterly Results Communication

Read more ››

By: GlobenewsWire - 03 Apr 2020

Sanofi: Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years

Read more ››

By: GlobenewsWire - 03 Apr 2020

APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19

Read more ››

By: GlobenewsWire - 02 Apr 2020

Related companies: APEIRON Biologics AG

Sanofi: Information on Sanofi’s Shareholder General Meeting of Tuesday, April 28, 2020

Read more ››

By: GlobenewsWire - 01 Apr 2020

Valneva Announces the Publication of its 2019 Universal Registration Document

Read more ››

By: GlobenewsWire - 31 Mar 2020

Novo Nordisk A/S - Share repurchase programme

Read more ››

By: GlobenewsWire - 30 Mar 2020

Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

Read more ››

By: GlobenewsWire - 30 Mar 2020

Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19

Read more ››

By: GlobenewsWire - 27 Mar 2020

Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma

Read more ››

By: GlobenewsWire - 27 Mar 2020

Sanofi: information concerning the total number of voting rights and shares, February 2020

Read more ››

By: GlobenewsWire - 26 Mar 2020

Resolutions from the Annual General Meeting of Novo Nordisk A/S

Read more ››

By: GlobenewsWire - 26 Mar 2020

Novo Nordisk A/S - Articles of Association

Read more ››

By: GlobenewsWire - 26 Mar 2020

Valneva Reports Positive End-of-Phase 2 Chikungunya Meeting with the U.S. FDA; Sets Stage for Phase 3 Study

Read more ››

By: GlobenewsWire - 25 Mar 2020

Sanofi successfully prices EUR 1.5 billion of bond issue

Read more ››

By: GlobenewsWire - 24 Mar 2020

Valneva Provides Business Update on COVID-19 Situation

Read more ››

By: GlobenewsWire - 24 Mar 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 23 Mar 2020

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update

Read more ››

By: GlobenewsWire - 19 Mar 2020

Related companies: HOOKIPA Pharma Inc.

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 16 Mar 2020

Novo Nordisk pauses the clinical trials investigating concizumab (anti-TFPI mAB) in haemophilia A and B with or without inhibitors

Read more ››

By: GlobenewsWire - 16 Mar 2020

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

April 2020
- : BioTrinity 2020 - DIGITAL EVENT
May 2020
- : Venture Summit | West
- Vienna: Nano Drug Delivery 2020

Add an Event »

Latest company news

Rybelsus® (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU
04 Apr 2020 (GlobenewsWire)

Sanofi: Availability of the Pre-quarterly Results Communication
03 Apr 2020 (GlobenewsWire)

Sanofi: Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years
03 Apr 2020 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com